These data indicate that the elevation of serum AFP/AFP-L3 levels correlate with the expression of two or more HPC markers in HCC, suggesting that these tumours had a more severe malignant phenotype compared to those positive for a single HPC marker. This evidence concerns the gene AFP and hepatocellular carcinoma.